Filtration based assessment of CTCs and CellSearch® based assessment are both powerful predictors of prognosis for metastatic breast cancer patients.
Huebner H, Fasching PA, Gumbrecht W, Jud S, Rauh C, Matzas M, Paulicka P, Friedrich K, Lux MP, Volz B, Gass P, Häberle L, Meier-Stiegen F, Hartkopf A, Neubauer H, Almstedt K, Beckmann MW, Fehm TN, Ruebner M.
Huebner H, et al. Among authors: neubauer h.
BMC Cancer. 2018 Feb 20;18(1):204. doi: 10.1186/s12885-018-4115-1.
BMC Cancer. 2018.
PMID: 29463222
Free PMC article.